Synthetic drugs for the treatment of vitiligo: a patent review (2010

Synthetic drugs for the treatment of vitiligo: a patent review (2010–2015)

Published:2016-07-29 Issue:10 Volume:26 Page:1175-1187
ISSN:1354-3776
Container-title:Expert Opinion on Therapeutic Patents
language:en
Short-container-title:Expert Opinion on Therapeutic Patents

Author:

de Menezes Andreia Freire,Shanmugam Saravanan,Gomes Isla Alcântara,de Carvalho Fernanda Oliveira,Quintans-Júnior Lucindo José,Gurgel Ricardo Queiroz,de Santana Silva Bruno,Serafini Mairim Russo,Araújo Adriano Antunes de Souza

Funder

Conselho Nacional de Desenvolvimento Científico e Tecnológico/CNPq/Brazil

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1080/13543776.2016.1215434

Reference42 articles.

1. Identification of categories at risk for high quality of life impairment in patients with vitiligo

2. The ACE gene I/ D polymorphism is not associated with generalized vitiligo susceptibility in Gujarat population

3. Vitiligo: Compendium of clinico-epidemiological features

4. Clinical Pattern of Vitiligo in Libya

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic and cosmeceutical role of glycosylated natural products in dermatology;Phytotherapy Research;2023-02-21

2. Formulation and characteristic evaluation of tacrolimus cubosomal gel for vitiligo;Journal of Dispersion Science and Technology;2022-11-14

3. The role of cytokines and vitamin D in vitiligo pathogenesis;Journal of Cosmetic Dermatology;2022-09-05

4. Development of a Multi-Target Strategy for the Treatment of Vitiligo via Machine Learning and Network Analysis Methods;Frontiers in Pharmacology;2021-09-15

5. Impact of missense mutation (rs1990760) at interferon-induced helicase (1) gene on non-segmental vitiligo;Gene Reports;2020-12